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A 66-year-old woman presented with progressive lancinating pain and sensory deficits attributable to a myelopathy of unclear
etiology. Spinal cord magnetic resonance imaging showed a longitudinally extensive T2-hyperintense lesion of the dorsal
columns. Comprehensive serum, urine, and cerebrospinal fluid analyses failed to identify an etiology. Empiric intravenous
methylprednisolone and intravenous immunoglobulin were of no benefit and serial screens for an occult malignancy were negative.
She developed dysesthesias and allodynia affecting her entire body and lost the use of her arms and legs due to severe sensory
ataxia that was steadily progressive from onset. She opted against additional aggressive medical management of her condition and
passed away on hospice eleven months after symptom onset. Autopsy revealed findings most consistent with polyphasic spinal
cord ischemia affecting the dorsal and lateral white matter tracts and, to a lesser extent, adjacent gray matter. The underlying
etiology for the progressive vasculopathy remains unknown. Spinal cord ischemia affecting the posterior spinal cord is rare and
to our knowledge this case represents the only instance of a progressive spinal cord tractopathy attributable to chronic spinal cord
ischemia.
1. Introduction
Dorsal column myelopathies commonly present with a
chief complaint of ataxia and incoordination. Exam findings
include loss of proprioception (leading to sensory ataxia),
vibration sense, two-point discrimination and light touch
with preserved pain, and temperature sensation [1, 2].
The differential diagnosis includes infectious, inflammatory
(including autoimmune, paraneoplastic, and demyelinating),
metabolic, toxic, and vascular (e.g., dural arteriovenous
fistula) etiologies which may be seen as longitudinally exten-
sive T2 hyperintensity localized to the dorsal columns on
magnetic resonance imaging (MRI, see “Differential Diag-
nosis of Chronic Myelopathy”) [2–11]. Although exceedingly
rare, posterior cord syndromes can also be associated with
an ischemic infarct of the spinal cord [5]. However, cases
of dorsal spinal cord ischemia reported in the literature
are associated with typical temporal features of a vascular
disorder, including acute onset and monophasic course
[5, 6].
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(vi) Paraneoplastic (most common antibodies)
(a) amphiphysin immunoglobulin G [IgG]
(b) collapsin response-mediator protein 5 IgG
(c) Purkinje-cell cytoplasmic autoantibody type 1, 2
(d) antineuronal nuclear autoantibody (ANNA-1),
and ANNA-3
(vii) Neuromyelitis optica (NMO) and NMO spectrum
disorders
(a) Aquaporin-4 IgG
(b) Myelin-oligodendrocyte glycoprotein (MOG)
IgG (rare in adults)
(c) Seronegative NMO (controversial entity)
(viii) Multiple sclerosis
(ix) Sarcoidosis
(x) CLIPPERS (chronic lymphocytic inflammation with
pontine perivascular enhancement responsive to
steroids)
(xi) Acute disseminated encephalomyelitis (ADEM) (rare
in adults)
Vascular
(i) Spinal cord infarction
(ii) Arteriovenous malformations
(iii) Diffuse atherosclerosis
(iv) Dural arteriovenous fistula
Hereditary/Degenerative
(i) Primary lateral sclerosis
(ii) Hereditary spastic paraparesis
(iii) Spinocerebellar ataxias
(iv) Mitochondrial disorders













(i) Human immunodeficiency virus (HIV)
















We present the case of a woman with a predominantly
progressive posterior cord syndrome of unclear etiology.
Autopsy findings suggest that chronic, progressive microvas-
culopathy should be considered in the differential diagnosis
of a dorsal column myelopathy when alternative, more
common, etiologies have been ruled out.
2. Case Presentation
A 66-year-old woman presented with lancinating pain, allo-
dynia, and numbness that steadily ascended from her feet
to the level of her umbilicus over a three-month period.
There was no clinical history to suggest an episodic or
relapsing-remitting course. Her past medical history was
significant for tobacco use, hypertension, poorly controlled
type II diabetes mellitus, chronic kidney disease, chronic
obstructive pulmonary disease, breast cancer (ductal carci-
noma, otherwise unspecified; 13 years after mastectomy and
reconstruction, not requiring chemotherapy), and a ruptured
hepatic abscess (8 years after abdominal wall reconstruction).
She had no known history of nitrous oxide exposure. Her
Case Reports in Neurological Medicine 3
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Figure 1: Sagittal T2-weighted MR images through the cervical (a) and thoracic (b) spine demonstrate diffuse, hyperintense signal in the
posterior columns, extending nearly the entire length of the spinal cord. An axial T2W image at T9-T10 (c) demonstrates the cross-sectional
extent of the signal abnormality.
neurologic examination showed normal mental status and
cranial nerves and a normalmotor examwhenutilizing visual
feedback to guide movement of the muscle groups being
tested. She had no visual field deficits on bedside testing
and there were no other clinical signs or symptoms of optic
neuropathy. Joint position sensewas severely impaired, with a
corresponding severe sensory ataxia and impaired upper and
lower extremity vibration sense (distal worse than proximal).
Reflexes were symmetrically brisk (3+). Bilateral Babinski
and Hoffman’s signs were elicited.
MRI of the cervical and thoracic spine was obtained
at the time of presentation and demonstrated mild, diffuse
atrophy of the cord and a diffuse hyperintense signal on T2-
weighted images within the dorsal columns, extending from
the craniocervical junction to T12 (Figure 1). A low creatinine
clearance precluded a contrast enhanced MRI of the spine
and spinal angiography to evaluate for a dural arteriovenous
fistula (AVF). MRI of the brain showed punctate T2 white
matter hyperintensities, a finding felt to be most consistent
with small vessel disease in this clinical context.
3. Clinical Discussion
The differential diagnosis for a dorsal column predominant
“tractopathy” is broad and includes infectious, inflamma-
tory/autoimmune/demyelinating, metabolic, toxic, and vas-
cular (e.g., dural arteriovenous fistula or rarely ischemic
infarction) etiologies (see “Differential Diagnosis of Chronic
Myelopathy”). A lesion involving the dorsal columns sym-
metrically and extending over so many spinal levels with
commensurate cord atrophy might suggest a metabolic pro-
cess such as subacute combined degeneration from vita-
min B12 deficiency or copper-deficiency myeloneuropathy.
However, chronic sequelae from syphilis (tabes dorsalis) or
HIV (vacuolar myelopathy) could have the same appearance.
In contrast, homogenous extension over such a long spinal
segment, without contrast enhancement, would be unusual
for a demyelinating disease, such as multiple sclerosis or
neuromyelitis optica (NMO), or for a neoplasm. Although
intravascular B cell lymphoma (IVBCL) can present with
longitudinally extensive spinal cord lesions, this neoplasm
would be expected to cause expansion of the cord and is rarely
predominantly tract specific [13].
Paraneoplastic myelopathies, on the other hand, are
commonly tract specific [8, 14–16]. Antineuronal nuclear
antigen 1 (ANNA-1, also known as anti-Hu), antineuronal
nuclear antigen 2 (ANNA-2), antineuronal antigen 3 (ANNA-
3), antiamphiphysin, and anticollapsing response mediator
protein 5 (CRMP-5) are among the most common antibodies
identified in patients with paraneoplastic myelopathies [17].
However, antibodies directed against a number of other
surface and intracellular antigens have also been reported
[8, 18]. Paraneoplastic myelopathies have been reported in
association with many forms of cancer, the most common
being breast and lung cancer [17].
4. Diagnostic Evaluation and Management
An extensive evaluation for metabolic/toxic (vitamin B12
deficiency, copper deficiency, vitamin E deficiency, and heavy
metals), infectious (bacterial (syphilis), viral (HIV, fungal,
and tuberculosis)), and autoimmune etiologies (NMO, MS,
and sarcoidosis) was nondiagnostic (Table 1). Neurosyphilis
was excluded by the absence of pleocytosis on CSF analysis
and a negative serum RPR and CSF VRDL. A purified-
protein derivative skin test for tuberculosis was negative. A
serum paraneoplastic autoantibody panel including antis-
triated muscle, antiacetylcholine receptor (ganglionic neu-
ronal), voltage-gated calcium channel P/Q type, anti-CRMP-
5 IgG, antineuronal nuclear 1, 2, 3, anti-Purkinje cell cyto-
plasmic types 1 and 2 and TR, antiamphiphysin, antiglial
nuclear, antineuronal voltage-gated potassium channel, and
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Table 1: Relevant data.
Plasma/serum/urine
Vitamin B12 (211–911 pg/mL) 524 pg/mL
Methylmalonic acid (≤0.40 nmol/L) 0.31 nmol/L
Homocysteine (5–15 𝜇mol/L) 11.7 𝜇mol/L
Vitamin E (5.5–17.0mg/L) 17.7mg/L
TSH (0.35–5.50mcIU/mL) 1.07mcIUnits/mL
Free T4 (0.9–1.8 ng/dL) 1.12 ng/dL
𝛽2-Microglobulin (1.1–2.5mg/L) 4.4mg/L
ANA, ANCA, anti-dsDNA, ENA Negative
24-hour urine heavy metals (mercury, lead, arsenic) Negative
24-hour urine zinc (300–600mcg/24 h) 909mcg/24 hr
24-hour urine copper (15–60mcg/24 h) 22mcg/24 hr
Serum paraneoplastic panel × 2∗ 0.03 and 0.04 nmol/L
Negative except for calcium channel ab N-type (<0.03)
Pathology
CSF cytology Negative
Fine needle aspiration of right paratracheal lymph node Negative
Skin biopsy Negative for lymphoma









Respiratory cultures from bronchoalveolar lavage Negative
CSF culture × 2 Negative
Fungal culture of blood Negative
CSF Jun 14 Aug 14
Glucose 113mg/dL 120mg/dL
Protein (15–45mg/dl) 30mg/dL 41mg/dL
Nucleated cells (cells/𝜇L) 0 0
Red blood cells 0 0
CSF IgG index (≤0.85) 0.6 0.62
CSF specific oligoclonal bands 0 0
CSF paraneoplastic panel∗ Negative
CSF cytology
Electromyography (EMG)/ nerve conduction study
Length-dependent sensorimotor axonal polyneuropathy with small sural sensory nerve action potential amplitudes and EMG evidence
of subacute and chronic neurogenic changes limited to a distal leg muscle.
TSH, thyroid stimulating hormone; HIV, human immunodeficiency virus; HTLV, human T-lymphotropic virus; RPR, rapid plasma reagin; ANA, anti-nuclear
antibody; ANCA, anti-neutrophil cytoplasmic antibody; dsDNA, double-stranded DNA; ENA, extractable nuclear antigen.
∗Paraneoplastic panel: antistriated muscle; antiacetylcholine receptor (ganglionic neuronal); anti-voltage-gated calcium channel binding P/Q type; CRMP-
5 IgG; antineuronal nuclear 1, 2, 3; Purkinje cell cytoplasmic types 1 and 2 and TR; amphiphysin, antiglial nuclear; antineuronal voltage-gated potassium
channel; and anti-GAD65 antibodies. CSF panel tested with indirect immunofluorescence assay and serum panel tested with indirect immunofluorescence
assay and radioimmunoassay (RIA) [12].
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anti-GAD65 antibodies, as well as serum aquaporin-4 IgG
was performed by Mayo Clinic, Rochester, Minnesota [12].
This panel was borderline positive for N-type voltage-
gated calcium channel (VGCC) antibodies at a titer of
0.03 nM on an initial sample and 0.04 nM on a repeat
sample sent two months after her initial presentation. The
patient underwent extensive screening for an occult malig-
nancy, including a whole body positron emission tomogra-
phy/computed tomography (PET/CT) scan, mammography,
and colonoscopy, all of which were negative/nondiagnostic.
PET scan did showFDG-avid lesions in lung parenchyma and
paratracheal nodes which prompted biopsy of the paratra-
cheal nodes which were negative for malignancy and showed
no granulomatous disease. Electromyography and nerve
conduction studies showed a mild, axonal, length-dependent
sensorimotor polyneuropathy. A quadriceps biopsy per-
formed to screen for IVBCL showed chronic neurogenic
changes of increased fiber size variation, pyknotic nuclear
clumps, and grouped atrophy with fiber type grouping.
A skin biopsy also showed no evidence of intravascular
B cell lymphoma. Empiric intravenous methylprednisolone
(3 of 5 grams completed over 3 days, with the final two
grams held due to significant hyperglycemia) and intravenous
immunoglobulin (IVIg, 2 g/kg) were of no benefit. After
discharge her disease continued to steadily progress and she
was readmitted 3 weeks later with worsened upper limb
sensory ataxia, rendering her unable to feed herself or live
independently.Her allodynia andpain had similarly escalated
and were no longer responsive to symptomatic therapies.
Two additional IVIg (1 g/kg/month) treatments were of no
benefit. Given her intractable pain, bedbound status with
a hospitalization for pneumonia, and 100% dependency for
all activities of daily living, she was placed on comfort care
through home hospice. She passed away eleven months after
onset of symptoms.
5. Neuropathologic Findings
Postmortem examination confirmed the cause of death
as bilateral pneumonia with multiple flora and foreign
material (consistent with aspiration) and found severe dif-
fuse atherosclerosis within the aorta from the arch to the
bifurcation, with evidence of ulceration. No neoplasm was
detected. Gross examination of the spinal cord revealed
atrophy and mild discoloration. Microscopic examination of
the spinal cord showed a complex polyphasic myelopathy
affecting dorsal and lateral white matter tracts and, to a
lesser extent, adjacent gray matter. More specifically, the
dorsal columns showed degeneration in a medial-to-lateral
gradient, with evidence of acute, subacute, and chronic
changes. The more acute/subacute changes included a neu-
trophilic infiltrate limited to the medial portions of the
dorsal columns, appearing in associationwith acute/subacute
necrosis, reactive/reparative vasculature, activated microglia,
and numerous foamy macrophages (Figure 2). The chronic
changes included loss of myelinated axons (Figures 3 and 4).
Similar chronic changes were observed within the lateral cor-
ticospinal tracts, with extension into the ventrolateral white
matter and adjacent gray matter (Figure 5). The superficial
white matter and ventral-most areas of white and gray matter
were relatively spared.
Outside the areas of injury, blood vessels in the spinal cord
showed only moderate arteriolosclerosis, without inflamma-
tion or thrombosis. Similar arteriolosclerosis was evident
in the brain and meninges. The brainstem showed only
very focal coarse vacuolation of the right spinothalamic
tract and ventral spinocerebellar tract in the lateral medulla;
other ascending and descending tracts were unremarkable.
Sections of sampled dorsal root ganglia showed no evidence
of nodules of Nageotte or of ganglion cell damage or loss.
The feeding vessels of the vertebral and spinal arteries,
which originate from the aorta, were not collected during
prosection, so subsequent histopathologic examination of
these vessels was not possible.
This pattern of spinal cord injury, involving the dorsal
columns in a gradient of severity from medial (worst) to
lateral (less severe) and also involving the dorsolateral white
matter, correlated with the clinical history of ascending
sensory symptoms. Coupled with damage to gray matter, this
pattern also raised suspicion for chronic ischemia/infarction
as an etiology for the patient’s myelopathy.
6. Discussion
This case is unique and instructive for both the spatial
(predominantly posterior columns on imaging with involve-
ment of additional tracts on tissue analysis) and temporal
(subacute-to-chronic and steadily progressive) pattern of
myelopathy, presumed secondary to a polyphasic ischemic
process. Typically, spinal cord infarction presents with an
acute onset of deficits that vary based on the territories
involved. Overall, nontraumatic spinal cord ischemia or
infarction accounts for only ∼1% of total strokes [17]. Usually,
spinal cord ischemia/infarction results from hypoperfusion
of the thoracolumbar spinal cord, which can occur in the
settings of atherosclerotic disease of the aorta or verte-
bral arteries, dissecting aortic aneurysm, aortic surgical
intervention, spinal trauma, or systemic hypotension [5].
Less common etiologies include vasculitis, cocaine abuse,
presumed fibrocartilaginous embolism, decompression sick-
ness, subclavian vein catheterization, sympathectomy, thora-
coplasty, celiac plexus neurolysis, lumbar epidural anesthesia,
intrathecal injection of lidocaine, dural arteriovenous fistula,
intramedullary arteriovenous malformation, single radicu-
lar artery ligation, vertebral angiography, and renal artery
embolization [5, 19]. Infarction of the posterior columns can
be related to vertebral artery dissection and trauma of the
spine or surgery.The histopathologic sequelae of ischemia are
variable and depend on both the level and extent of vascular
compromise. Autopsy findings in patients affected by spinal
cord infarction often include preferential involvement of gray
matter; however, in a large series, the most severe cases also
showed white matter necrosis [18, 20]. Other reports describe
involvement of both gray and white matter [21]. With respect
to vascular territories, infarction localized predominantly to
the region supplied by the posterior spinal arteries is very
rare and the pathophysiology has not been clearly defined
[17, 21]. Because the posterior columns have a consistent
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Figure 2: Acute and subacute ischemic changes in the spinal cord. (a, b) Intermediate-power and high-power photomicrographs of dorsal
columns in a section with neutrophilic infiltrates and reactive vessels (original magnifications, ×40 and ×400, resp.; H-E stain); (c) low-
power photomicrograph of spinal cord stained with antibody against CD68 to demonstrate foamy macrophages and microglia, primarily
within dorsal columns and lateral white matter tracts (original magnification, ×20; CD68 immunostain); (d) higher-power photomicrograph
of the dorsal columns showing CD68-positive macrophages and microglia (original magnification, ×200; CD68 immunostain).
blood supply from two posterior spinal arteries and the large
number of anastomoses, it is hypothesized that this region is
often spared [5, 6, 22]. However, in cases of hypoperfusion, a
watershed effect may take precedence [17]. In the spinal cord,
there is a dorsal watershed zone characterized by a capillary
networkwhere the penetrating branches of the anterior spinal
artery meet the penetrating branches of the posterior spinal
arteries and branches of the circumferential pial network [17].
This vascular anatomy may also contribute to the neurologic
manifestations of chronic spinal cord ischemia in the setting
of arteriovenous malformations and AVFs.
Signs and symptoms of spinal cord ischemia may vary in
intensity and evolve over a few days before deficits become
fixed. This patient presented with a subacute-to-chronic
history of pain and severe sensory ataxia, and MRI findings
supported localization to the posterior cord; accordingly, our
initial differential diagnosis focused on common causes of
this form of myelopathy. This patient did not fit the typical
case of spinal cord infarction as she had no acute inciting
event and it is uncommon for spinal cord infarction to
preferentially involve the dorsal columns [5, 6, 17, 22, 23]. Fur-
thermore, these acute inciting events have a much stronger
association with anterior, rather than posterior, spinal cord
infarctions in the literature [17]. A spinal angiogram (to
evaluate for a dural AVF) was not possible in the setting of
the patient’s low creatinine clearance.
The underlying etiology of this patient’s apparent poly-
phasic spinal cord infarction remains unclear. The lack of
an inflammatory CSF profile, nodular contrast enhancing
lesions in the spine (typical of sarcoidosis), nondiagnostic
paratracheal lymph node biopsy guided by results of a full
body PET scan, and lack of pathologic features of non-
caseating granulomas on complete autopsy, all argued against
neurosarcoidosis. The patient’s serum anti-aquaporin-4 IgG
was negative and other than radiologic evidence of a lon-
gitudinally extensive lesion of the dorsal columns there
were no clinical features suggestive of NMO or NMOSD.
Radiological and postmortem examinations identified severe
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Figure 3: Histologic sections of spinal cord demonstrate extensive white matter pathology. (a) Low-power photomicrograph of spinal cord
with dorsal column and lateral white matter degeneration (original magnification, ×20; hematoxylin-eosin [H-E] stain); (b) low-power
photomicrograph of spinal cord stained with Luxol fast blue-periodic acid Schiff (LFB-PAS) histochemistry to demonstrate loss of myelinated
axons (original magnification, ×20; LFB-PAS stain).
(a)
(b) (c)
Figure 4: Spinal cord stained immunohistochemically with antibody to neurofilament (NF) demonstrates regional axonal loss; (a) low-
power photomicrograph demonstrates areas of axonal loss most pronounced in the dorsal (upper boxed area) and lateral white matter tracts,
in contrast to ventral spinal cord (lower boxed area) (original magnification, ×20; NF immunostain); (b, c) higher-power photomicrographs
of boxed areas to demonstrate axonal loss in dorsal columns ((b) upper boxed area from (a)) with relative axonal preservation in ventral area
((c) lower boxed area from (a)) (original magnifications, ×200; NF immunostain).
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Figure 5: Gray matter damage. (a) Lower-power photomicrograph of gray matter adjacent to ventrolateral tracts (original magnification,
×40; H-E stain); (b) higher-power photomicrograph of adjacent gray matter with neuronal loss and gliosis (original magnification, ×400;
H-E stain).
atherosclerosis in the aorta and visceral blood vessels, but
there was no definitive evidence of thrombosis or vasculitis
to explain the more acute changes. Given the symmetric,
tract specific changes on imaging, symmetric clinical deficits,
and the progressive course, a paraneoplastic myelopathy
remains possible, despite the lack of an identified occult
malignancy at autopsy or on PET/CT scan. Although VGCC
autoantibodies have been reported in cases of paraneoplastic
myelopathy they are not specific to this disorder; and, given
the low titers, this finding has unclear clinical significance
[14, 16]. Nonetheless, given the many factors suggestive of a
paraneoplastic etiology and the possibility of an unidentified
antibody-mediated disorder, the patient underwent exten-
sive screening for an occult malignancy, including a whole
body positron emission tomography/computed tomography
(PET/CT) scan, mammography, and colonoscopy. PET/CT
scans certainly improve the likelihood of identifying an occult
malignancy in suspected paraneoplastic disorders but are
not 100% sensitive and in this case serial PET scans did
not identify a malignancy [24, 25]. The unusual findings of
ischemia/infarction suggest that if this were paraneoplastic in
nature, it would be associated with a novel form of a para-
neoplastic microvasculopathy [14]. The pathologic features
of paraneoplastic myelopathies are not well characterized,
precluding a comparison of our findings to others reported
in the literature.
7. Conclusion
Chronic, progressive microvasculopathy should be consid-
ered in the differential diagnosis of a progressive myelopathy
with imaging evidence of a dorsal column tractopathy when
alternative, more common, etiologies have been ruled out.
Given the strong suspicion for an occult malignancy in
our case and the strong clinical resemblance to previously
reported cases of paraneoplastic dorsal column myelopathy,
we propose that an immune mediated microvasculopathy be
considered in the list of potential pathophysiologic mecha-
nisms for paraneoplasticmyelopathies. To our knowledge, no
comparable cases exist in the literature and additional cases
are necessary to further test this hypothesis, emphasizing the
importance of postmortem examinations in this unfortunate
patient population.
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